NeoGenomics, Inc. NEO
Analyst Ratings
- Consensus
- Buy — 7 Buy · 0 Hold · 0 Sell (7 analysts)
- Avg. Price Target
- $19.71 (+21.4% upside)
Key Stats
- Today's Range
- $16.13 – $16.35
- 50-Day Range
- $15.34 – $20.15
- 52-Week Range
- $7.07 – $20.15
- Volume
- 96K shs
- Average Volume
- 2.16 million shs
- Market Cap
- $2.10 billion
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 6.94%
- Days to Cover
- 34.38
About NeoGenomics, Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
Related Stocks
Compare head-to-head: NEO vs NVDA·NEO vs AAPL·NEO vs GOOGL·NEO vs GOOG
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.